Previous research has shown that focal therapy for prostate cancer can prolong life, result in less complications such as incontinence, and improve post-treatment quality of life.
But the long-term effectiveness of focal treatments has not been well-studied. A new analysis that followed patients treated with optimized cryoablation of prostate cancer for an average of 10 years post-treatment is published in Journal of Men's Health, a peer-reviewed publication from Mary Ann Liebert, Inc. The article is available free on the Journal of Men's Health website.
Prostate Cancer Screening
PSA (Prostate Specific Antigen) test and Digital Rectal Examination are two tests that allow detection of prostate cancer at early stages.
Advertisement
In the article "Long-Term Results Of Optimized Focal Therapy Of Prostate Cancer: Average 10-Year Follow-Up in 70 Patients," Gary Onik, MD, Carnegie Mellon University (Fort Lauderdale, FL), and coauthors found that long-term cancer control with focal cryoablation therapy was superior to radical whole gland treatments in patients at medium or high risk for disease-free survival.
Source: Eurekalert
Prostate Cancer: Treatment Options
Treatment options of prostate cancer includes waiting, surgery, radiation, hormone therapy, chemotherapy, cryosurgery or biologic therapy.
Advertisement
Advertisement
|
Advertisement
Recommended Readings
![Prostate Specific Antigen [PSA]](https://www.medindia.net/images/patientinfo/120x100/prostate-specific-antigen.jpg "Prostate Specific Antigen [PSA]")
Latest Cancer News
Researchers found a pathway linked to allergies that, when blocked, triggers antitumor immunity in lung cancer mouse models.
The occurrence of epimutations early in pregnancy challenges traditional theories related to carcinogenesis and the risk of developing breast cancer.
More affected relatives, higher lung cancer risk; participants with affected mothers or siblings faced increased risk.
Colorectal cancer can be lowered by up to 7% by increasing dietary consumption of folate rich foods like spinach, broccoli or taking folate supplements.
The effects and mechanisms of microRNA-451a (miR-451a), which hinders the progression of gemcitabine-resistant biliary tract cancers, are under study.